Using Virtual Reality to Control the Audio-visual Inputs During Ketamine/Esketamine Treatment

Part of paid clinical trials in New Haven, Connecticut.

Sponsor
Yale University
Study ID
NCT06139016
Status
Enrolling By Invitation

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Virtual reality — DEVICE
    Virtual reality gear and content will be used to affect and control the audiovisual perception of patients during a single treatment with ketamine/esketamine

Study Details

Investigators aim to examine the role of audiovisual inputs during treatment with ketamine/esketamine in affecting tolerability and effectiveness of treatment of depressive episodes, by providing patients with a relaxing environment using virtual reality goggles and noise cancelling headphones, and assessing whether these tools can improve the tolerability and effectiveness of treatment with ketamine/esketamine

Key Dates

Start date
Jul 11, 2024
Status verified
Feb 2025
Primary completion
Jun 30, 2025
Completion
Dec 31, 2025

Study Design

Enrollment
10 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Treatment group
    This single arm will include all participants of the study, who will all receive the intervention

Primary Outcome Measure

Tolerability of VR treatment assessed by qualitative report [ Time Frame: baseline and Immediately post-VR treatment ]

Locations (1)

FacilityCityStateZIPSite coordinators
Yale Psychiatry Hospital Interventional Psychiatry Services (IPS) unitNew HavenConnecticut06520-

Find similar trials in New Haven, CT

By condition
Depression
By specialty
PsychiatryMental healthBehavioral health
By research site
Yale Psychiatry Hospital Interventional Psychiatry Services (IPS) unit· New Haven, CT

Related Studies